新型冠状病毒肺炎前100篇高被引论文的文献计量与可视化分析  

The 100 top-cited papers on corona virus disease 19:A bibliometric and visualized analysis

作　　者：屈清慧 张馨洋 黄崇亚 孟歌[4] 鲁云舒 常捷 QU Qinghui;ZHANG Xinyang;HUANG Chongya;MENG Ge;LU Yunshu;CHANG Jie(Editorial Board of Northwest Pharmaceutical Journal,School of Pharmacy,Health Science Center,Xi’an Jiaotong University,Xi’an 710061,China;AVIC Xi’an Flight Automatic Control Research Institute,Xi’an 710065,China;Periodical Center,Xi’an Jiaotong University,Xi’an 710061,China;Engineering Center of Catalysis and Synthesis for Chiral Molecules,Department of Chemistry,Fudan University,Shanghai 200433,China;Department of Pharmacy Administration and Clinical Pharmacy,School of Pharmacy,Health Science Center,Xi’an Jiaotong University,Xi’an 710061,China)

机构地区：[1]西安交通大学医学部药学院《西北药学杂志》编辑部,西安710061 [2]中航工业西安飞行自动控制研究所,西安710065 [3]西安交通大学期刊中心,西安710061 [4]复旦大学化学系手性分子催化与合成工程中心,上海200433 [5]西安交通大学医学部药学院药事管理与临床药学系,西安710061

出　　处：《西北药学杂志》2023年第5期197-209,共13页Northwest Pharmaceutical Journal

基　　金：国家自然科学基金项目(编号:21871055);中国高校科技期刊研究会“一流高校科技期刊建设”专项基金项目(编号:CUJS2021-21)。

摘　　要：目的用文献计量学方法总结和可视化新型冠状病毒肺炎(corona virus disease 19,COVID-19)影响最大的出版物的模式、趋势和重点。方法以“COVID-19”为检索词,在Web of Science Database数据库中进行检索,得到引用次数最多的COVID-19主题前100篇文章的信息,进行文献计量分析,用VOSviewer软件进行可视化分析。结果100篇最高被引文章的总被引量为186386次。我国早期对COVID-19临床和流行病学特征的研究已被大量引用,并呈持续快速增加的趋势。虽然临床、流行病学特征、病毒入侵机制仍是研究热点,但药物治疗、对心理健康的影响以及与慢性病共病已成为新出现的COVID-19研究课题,疫苗接种的有效性、病毒突变和对经济的影响仍有待研究。结论我国早期对COVID-19临床和流行病学特征的研究获得了大量引用,并不断形成对该病的基本认识。药物治疗、对心理健康的影响以及与慢性病共病已成为新出现的COVID-19研究课题。Objective To use a bibliometric method to summarize and visualize the patterns,trends,and focuses of the top impact publications on the corona virus disease 19(COVID-19).Methods By using“COVID-19”as the search term,a search in the Web of Science Database(WoS)was performed.The information of the top 100 papers on the COVID-19 topic with the highest citations was elicited.A bibliometric analysis was conducted,and then a visualized analysis was applied by using VOSviewer software.Results The total citations of the 100 top-cited papers was 186386.China’s early investigations on clinical and epidemiological features of COVID-19 received a high citation and increased quickly.The clinical and epidemiologic features and virus invasion mechanisms remain the hot topics.The drug treatment,the impact on mental health,and the comorbidity with chronic conditions are emerging topics on COVID-19 research.The effectiveness of vaccination,the viral mutation,and the economic impact still need to be studied.Conclusion China’s early investigations on clinical and epidemiological features of COVID-19 received a high citation and were continuously shaping the basic understanding of the disease.The drug treatment,the impact on mental health,and the comorbidity with chronic conditions have become emerging topics on COVID-19 research.

关 键 词：新型冠状病毒肺炎(COVID-19) 高被引论文 被引频次 文献计量学 可视化方法 科学网(WoS) 

分 类 号：R95[医药卫生—药学]